Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CARBIMAZOLE 5 TABLET 5 MG - HSA Drug Approval Details

Approvals/HSA/CARBIMAZOLE 5 TABLET 5 MG

Approved

THERAPEUTIC

CARBIMAZOLE 5 TABLET 5 MG

REMEDICA LTD (CYPRUS)🇸🇬 Health Sciences Authority

Approval Date: Mar 23, 1992
Approval ID: ccf963fba2b21b2f
Company: REMEDICA LTD (CYPRUS)
Type: Therapeutic

Approval Details

Approval Id: ccf963fba2b21b2f
Drug Name: CARBIMAZOLE 5 TABLET 5 MG
Product Name: CARBIMAZOLE 5 TABLET 5 MG
Approval Number: SIN06923P
Approval Date: 1992-03-23
Registrant: GOLDPLUS UNIVERSAL PTE LTD
Licence Holder: GOLDPLUS UNIVERSAL PTE LTD
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: TABLET, FILM COATED
Route Of Administration: ORAL
Atc Code: H03BB01
Atc Item Name: carbimazole
Pharma Manufacturer Name: GOLDPLUS UNIVERSAL PTE LTD

Active Ingredients

CARBIMAZOLE

5 mg

CARBIMAZOLE

5 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Mar 23, 1992

Approval ID

ccf963fba2b21b2f

Type

Therapeutic

Back to HSA Approvals